Liver Disease
Antibodies to soluble liver antigen and alpha-enolase in patients with autoimmune hepatitis.
J Autoimmune Dis 2004; 1(1):4. – DOI: 10.1186/1740-2557-1-4
Autoimmune liver serology: Current diagnostic and clinical challenges.
World J Gastroenterol 2008 June 7; 14(21): 3374-3387 – DOI: 10.3748/wjg.14.3374
Disease-specific autoantibodies in primary biliary cirrhosis.
Clin Chim Acta 412 (7-8):502-512, 2011.
Anti-gp210 antibody mirrors disease severity in primary biliary cirrhosis.
Hepatology 45 (6):1583-1584, 2007.
Antibodies to filamentous actin (F-actin) in type 1 autoimmune hepatitis.
J Clin.Pathol. 59 (3):280-284, 2006.
Primary biliary cirrhosis: what do autoantibodies tell us?
World J Gastroenterol. 16 (29):3616-3629, 2010.
Autoimmune hepatitis, from mechanisms to therapy.
Hepatology 2006; 43(2 Suppl 1):S132-S144. – DOI 10.1002/hep.21059
The relationship between autoimmune markers and different clinical syndromes in autoimmune hepatitis.
Gut 1998;42:599–602
The serological profile of the autoimmune hepatitis/primary biliary cirrhosis overlap syndrome
Am J Gastroenterol. 104 (6):1420-1425, 2009.
Non-muscle myosin as target antigen for human autoantibodies in patients with hepatitis C virus- associated chronic liver diseases
Clin Exp Immunol. 1995 April; 100(1): 67–74.
Autoimmune hepatitis-specific antibodies against soluble liver antigen and liver cytosol type 1 in patients with chronic viral hepatitis.
J Autoimmune.Dis 4:2, 2007.
Liver autoimmune serology: a consensus statement from the committee for autoimmune serology of the International Autoimmune Hepatitis
Group J Hepatol. 41 (4):677-683, 2004.
Identification of target antigen for SLA/LP autoantibodies in autoimmune hepatitis.
Lancet 2000; 355(9214):1510-5. – DOI:10.1016/S0140-6736(00)02166-8
Antinuclear antibodies specific for primary biliary cirrhosis.
Autoimmun.Rev 2 (4):211-217, 2003.
Autoantibodies and autoantigens in autoimmune hepatitis: important tools in clinical practice and to study pathogenesis of the disease.
Journal of Autoimmune Diseases 2004, 1:2 – DOI:10.1186/1740- 2557-1-2
Anti-smooth muscle antibodies (ASMAs) and anti-cytoskeleton antibodies (ACTAs) in liver diseases: a comparison of classical indirect immunofluorescence with ELISA.
J Clin Lab Anal 2002; 16(4):194-201.
Chlamydia trachomatis
Importance of species-specific antigens in the serodiagnosis of Chlamydia trachomatis reactive arthritis.
Rheumatology (Oxford). 2002 Sep;41(9):1017-20.
Identification and evaluation of a combination of chlamydial antigens to support the diagnosis of severe and invasive Chlamydia trachomatis infections.
Clin Microbiol Infect. 2010 Aug;16(8):1237-44.
The natural history and immunobiology of Chlamydia trachomatis genital infection and implications for Chlamydia control.
J Infect Dis. 2010 Jun 15;201 Suppl 2:S190-204.
Antigen specific serum antibody response to Chlamydia trachomatis in patients with acute pelvic inflammatory disease.
J Clin Pathol. 1990 Sep;43(9):758- 61.
Chlamydial protease- like activity factor – insights into immunity and vaccine development.
J Reprod Immunol . 2009 Dec;83(1-2):179-84. Review.
Detection of Antibodies to Chlamydia trachomatis With Peptide-Based Species-Specific Enzyme Immunoassay.
Infect Dis Obstet Gynecol. 1997;5(5):349-54.
Human antibody responses to a Chlamydia-secreted protease factor.
Infect Immun. 2004 Dec;72(12):7164-71.
A chlamydial type III-secreted effector protein (Tarp) is predominantly recognized by antibodies from humans infected with Chlamydia trachomatis and induces protective immunity against upper genital tract pathologies in mice.
Vaccine. 2009 May 14;27(22):2967-80.
Chlamydia pneumoniae
Chlamydia pneumoniae, stroke, and serological associations: anything learned from the atherosclerosis-cardiovascular literature or do we have to start over again?
Stroke. 2006 Mar;37(3):756-8.
The role of pulmonary infection in pediatric asthma.
Allergy Asthma Proc.
2007 Mar-Apr;28(2):190-3. Review.
Immunoproteomic identification and serological responses to novel Chlamydia pneumoniae antigens that are associated with persistent C. pneumoniae infections.
Allergy Asthma Proc.
J Immunol . 2008 Apr 15;180(8):5490-8.
Role of infection in the development and exacerbation of asthma.
Expert Rev Respir Med. 2010 Feb;4(1):71-83. Review.
Can acute Chlamydia pneumoniae respiratory tract infection initiate chronic asthma?
Ann Allergy Asthma Immunol . 1998 Oct;81(4):339-44.
Chlamydia pneumoniae serology: interlaboratory variation in microimmunofluorescence assay results.
J Infect Dis. 2000 Jun;181 Suppl 3:S426-9.
Serological diagnosis of Chlamydia pneumoniae infection: limitations and perspectives.
J Med Microbiol. 2010 Nov;59(Pt 11):1267-74.
Chlamydia pneumoniae major outer membrane protein is a surface- exposed antigen that elicits antibodies primarily directed against conformation-dependent determinants.
Infect Immun. 2001 May;69(5):3082-91.
Celiac Disease
Oral proteases: a new approach to managing coeliac disease.
Gut 2007;56;157-160. doi:10.1136/gut.2005.090498
Anti-tissue transglutaminase antibodies in the follow-up of adult celiac disease.
Aliment Pharmacol Ther. 2009 Aug;30(3):236-44.
Pre-endoscopy serological testing for coeliac disease: evaluation of a clinical decision tool
BMJ 2007; 334(7596):729. – doi:10.1136/bmj.39133.668681.BE
Celiac disease: pathogenesis of a model immunogenetic disease.
J Clin Invest 2007; 117(1):41-9. – doi:10.1172/JCI30253
Structural basis for HLA- DQ2-mediated presentation of gluten epitopes in celiac disease.
Proc Natl Acad Sci U S A 2004; 101(12):4175-9. – doi:10.1073/pnas.0306885101
Diagnostic accuracy of coeliac serological tests: a prospective study.
Eur J Gastroenterol Hepatol 2006; 18(5):493-501.
Emerging new clinical patterns in the presentation of celiac disease.
Arch Pediatr Adolesc Med 2008; 162(2):164-8.
Serologic assay based on gliadin-related nonapeptides as a highly sensitive and specific diagnostic aid in celiac disease.
Clin Chem. 2004;50:2370-5. – doi 10.1373/clinchem.2004.036111
For the ESPGHAN Working Group on Coeliac Disease Diagnosis, on behalf of the ESPGHAN Gastroenterology Committee.European Society for Pediatric Gastroenterology, Hepatology, and Nutrition Guidelines for the Diagnosis of Coeliac Disease.
J Pediatr Gastroenterol Nutr. 2012 Jan;54(1):136-60
Diagnostic accuracy of IgA anti-tissue transglutaminase antibody assays in celiac disease patients with selective IgA deficiency.
Ann N Y Acad Sci 2007; 1109:212-20. doi:10.1196/annals.1398.025
Testing for IgG class antibodies in celiac disease patients with selective IgA deficiency. A comparison of the diagnostic accuracy of 9 IgG anti-tissue transglutaminase, 1 IgG anti-gliadin and 1 IgG anti-deaminated gliadin peptide antibody assays.
Clin Chim Acta 2007; 382(1-2):95-9. – doi:10.1016/j.cca.2007.03.028
Antiphospholipid Syndrome
Diagnosis of antiphospholipid syndrome.
Nat Clin Pract Rheumatol. 2005 Nov;1(1):40-6. – doi:10.1038/ncprheum0017
Antiphospholipid antibody tests: spreading the net.
Ann Rheum Dis 2005;64:1639–1643. doi: 10.1136/ard.2005.035824
The antiphospholipid syndrome.
Semin Nephrol. 2007 Jan;27(1):35-46. – doi:10.1016/j.semnephrol.2006.09.006
How we diagnose and treat thrombotic manifestations of the antiphospholipid syndrome: a case-based review.
Blood, 2007 Nov 1;110(9):3122-7. – doi:10.1182/blood-2006-10-041814
Mechanisms of disease: antiphospholipid antibodies- from clinical association to pathologic mechanism.
Nat Clin Pract Rheumatol. 2008 Apr;4(4):192-9. – doi:10.1038/ncprheum0740
Phosphatidylserine IgG and beta-2-glycoprotein I IgA antibodies may be a risk factor for ischaemic stroke.
Rheumatology, 2005;44:1161-5. – doi:10.1093/rheumatology/keh698
Isotype distribution and clinical relevance of anti-beta2-glycoprotein I (beta2- GPI) antibodies: importance of IgA isotype.
Clin Exp Immunol. 1999;117:574-9.
Anticardiolipin, anti-beta(2)-glycoprotein I and antiprothrombin antibodies in black South African patients with infectious disease.
Ann Rheum Dis. 2003;62:1106-11. – doi: 10.1136/ard.62.11.1106
International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS).
J Thromb Haemost. 2006 Feb;4(2):295-306.
Strong correlation between the prevalence of cerebral infarction and the presence of anti-cardiolipin/beta2- glycoprotein I and anti-phosphatidylserine/prothrombin antibodies – Co-existence of these antibodies enhances ADP-induced platelet activation in vitro.
Thromb Haemost. 2004 May;91(5):967-76. – doi:10.1160/TH03-10-0608
Revised classification criteria for antiphospholipid syndrome and the thrombotic risk in patients with autoimmune diseases.
J Thromb Haemost. 2007 Sep;5(9):1883-9.
-
Kurznachricht: Markenidentität
15. April 2024
Die ORGENTEC Diagnostika GmbH ist Teil der Sebia-Gruppe und schließt sich daher der...
-
Besuchen Sie uns auf dem 14. Internationalen Kongress zur Autoimmunität und finden Sie uns im neuen Sebia-Messestand-Design
05. April 2024